BAY-298 |
BAY-298 : Antagonist of LHCGR
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| LHCGR |
|
Antagonist
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Functional, GPCR Off-Target Profiling of BAY 298 (Eurofins).
Compound was tested in both, antagonis ...
Potency Cellular
In Vitro
LHCGR
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.9b01382
In Vivo Validations
Rat
Dose: 0.5 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
31 h
Systemic clearance:
0.41 L/h/Kg
Cmax:
0.28 Kg/L
Area Under the Curve::
2.5 Kg*h/L
Volume of Distribution at Steady-State:
16 L/Kg
DOI Reference: 10.1021/acs.jmedchem.9b01382
Dose: 2.0 mg/Kg
Route of delivery:
Oral
Plasma half life:
33 h
Cmax:
0.066 Kg/L
Tmax:
8.0 h
Area Under the Curve::
2.7 Kh*h/L
Bioavailability:
108%
DOI Reference: 10.1021/acs.jmedchem.9b01382
Chemical Information
| Molecular Formula | C27H21ClFN3O2 |
| SMILEs | O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@@H]1c1ccc(Cl)cc1 |
| InChI | InChI=1S/C27H21ClFN3O2/c28-19-5-3-18(4-6-19)26-24-2-1-16-30-25(24)15-17-32(26)27(33)31-21-9-13-23(14-10-21)34-22-11-7-20(29)8-12-22/h1-14,16,26H,15,17H2,(H,31,33)/t26-/m0/s1 |
| Molecular weight | 473.13 Da |
| AlogP | 6.846000000000005 |
| HBond acceptors | 5 |
| HBond donors | 1 |
| Atoms | 55 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.